Log In
BCIQ
Print this Print this
 

Cilodex, CiproDex, ciprofloxacin/dexamethasone otic suspension

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionEar drop solution containing 0.3% ciprofloxacin and 0.1% dexamethasone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOtitis media
Indication DetailsTreat middle and outer ear infections
Regulatory Designation
PartnerBayer AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today